PDUFAPrescription Drug User Fee Act of 1992 (USA)
References in periodicals archive ?
"The first five years of PDUFA 1, as we called it, were a startling, unqualified success.
(Nasdaq:KPTI) revealed on Thursday that the US Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) action date for the New Drug Application (NDA) for selinexor for the treatment of relapsed refractory multiple myeloma.
The NDA will be subject to a standard review and will have a PDUFA action date of 24 January 2015.
With the industry's support, PDUFA was reauthorized in 1997 and again three years ago.
The two associations released a joint statement in which they credited PDUFA with helping the regulatory agency to keep pace with the rapid increase in the number and complexity of innovative drugs and biologics requiring regulatory review.
The stated goals for this version of the PDUFA include placing PDUFA on a sound financial footing, enhancing pre-market review, and creating a modern post-market drug safety system that follows products across their full life cycle.
WASHINGTON -- The Prescription Drug User Fee Act (PDUFA) has benefited not only the millions of Americans who rely on innovative drugs and biologics but also U.S.-based drug manufacturers as they compete around the world.
User fees for pre scription drug and biological products are currently authorized under the Prescription Drug User Fee Amendments of 2007 (PDUFA IV).
At the meeting sponsored by FDA, outside groups voiced concerns about the agency's proposal for the PDUFA program and made their case for how FDA should organize and spend requested funding, The Pink Sheet reports.
The company said it expects a complete response letter from the FDA on or before the PDUFA action date.
While it remains possible that the FDA may elect to convene an AdCom, with less than two months remaining prior to the PDUFA date Amarin is now assuming that an AdCom is unlikely.
M2 PHARMA-December 26, 2017-FDA Extends BioMarin PDUFA Date for Pegvaliase Biologics License Application